By TopClassActions  |  August 20, 2013

Category: Pharmaceuticals
Follow us on Twitter and Facebook for the latest Lipitor Diabetes Class Action Lawsuit & Settlement News!

 

New Lipitor Diabetes Lawsuit Filed by California Woman

By John Curran

 


Lipitor LawsuitCalifornia resident Aubrey Isom alleges in a new lawsuit against Pfizer Inc. that its prescription cholesterol drug, Lipitor, caused her develop type-2 diabetes. The Lipitor diabetes lawsuit was filed August 15, 2013.

Isom alleges in the Lipitor lawsuit that she began taking the medication in 2006 to lower her low-density lipoprotein, or LDL cholesterol, as part of an overall plan to reduce her risk for cardiovascular disease. She was diagnosed with type-2 diabetes about a year later – a side effect of Lipitor that neither she nor her doctor was aware of, according to the lawsuit.

Isom claims Pfizer should have known about the risk of Lipitor diabetes since it was patented and marketed in 2000. It was not until February 2012 that the company complied with a label change mandate from the FDA to update the warning for Lipitor side effects to include diabetes, although the lawsuit notes that it did so “in the most obtuse terms [regarding] a potential elevation of blood sugar.”


The lack of a clear indication of the risks of Lipitor type-2 diabetes side effects led Isom to claim a count of failure to warn in her lawsuit. She also alleges that studies should have been completed before the release of Lipitor on the market which would have warned patients and their doctors that the popular statin medication carried significant risks regarding the elevation of blood sugar.

The Lipitor lawsuit states that “Lipitor has been implicated in a national epidemic of type 2 diabetes in women taking” the cholesterol drug. As a result, counts against Pfizer include negligence, failure to warn, breach of implied and express warranties, deceit and fraud by concealment, negligent misrepresentation and several state statute violations.

The Lipitor type-2 diabetes lawsuit is Aubrey Isom v. Pfizer Inc., Case No. 12-cv-01250, U.S. District Court, Central District of California.

If you are a woman who was taking Lipitor and developed diabetes, you may have legal options available to you. Get educated at the Lipitor Diabetes Class Action Lawsuit Investigation. While there you can fill out a short form that is the first step in determining your eligibility. If you have a case, you will be contacted by a Lipitor lawsuit lawyer to review your potential case and what steps you can take moving forward. Statutes of limitations may apply, however, so it is important to act quickly.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.

One thought on New Lipitor Diabetes Lawsuit Filed by California Woman

  1. janell says:

    just be patience this drug has some real side effects.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.